Elevance Health (ELV) Treasury Shares (2009 - 2026)

Elevance Health (ELV) has 18 years of Treasury Shares data on file, last reported at $1.6 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $1.6 million, up 33.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 33.33% YoY), and the FY2025 annual result was $1.1 million, up 10.0% from the prior year.
• Treasury Shares grew to $1.6 million in Q1 2026 per ELV's latest filing, from $1.1 million in the prior quarter.
• Over five years, Treasury Shares peaked at $1.6 million in Q1 2026 and troughed at $1.0 million in Q3 2024.
• A 5-year average of $1.2 million and a median of $1.1 million in 2023 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2024 and 2026: Treasury Shares dropped 9.09% in 2024, then soared 33.33% in 2026.
• A 5-year view of Treasury Shares shows it stood at $1.2 million in 2022, then declined by 8.33% to $1.1 million in 2023, then slipped by 9.09% to $1.0 million in 2024, then advanced by 10.0% to $1.1 million in 2025, then soared by 45.45% to $1.6 million in 2026.
• Business Quant data shows ELV's Treasury Shares at $1.6 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.